Symptom Collection of Lung Cancer Patients
A Study on Symptom Collection of Patients With Lung Cancer.
1 other identifier
observational
100
1 country
1
Brief Summary
This study is conducted to collect the symptoms of lung cancer patients and to observe the relationship with proteomics.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2015
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 16, 2015
CompletedFirst Submitted
Initial submission to the registry
December 20, 2017
CompletedFirst Posted
Study publicly available on registry
December 27, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
May 31, 2018
CompletedJanuary 9, 2018
January 1, 2018
2.5 years
December 20, 2017
January 5, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Pattern identification
Pattern identification by Body constitution questionnaire(BCQ) BCQ(+) is a questionnaire that is comprised of nineteen questions with one-to-five rating scales, making the range of total score to be between nineteen and ninety-five points with the cut-off score of 30.5 points for Yang-Xu. BCQ(-) is composed of another set of nineteen questions with the same five-point Likert scales, with the cut-off score of 29.5 points for Yin-Xu. BCQ(s) consists of twenty-three questions with the same Likert scale cut-off score of 26.5 points for Stasis.
For 1 year
Eligibility Criteria
Patients with lung cancer who are scheduled for surgery will be enrolled.
You may qualify if:
- Adult over 18 years old
- Patients are scheduled for surgery with lung cancer diagnosis.
- ECOG status score 0 to 2
- Individual who can read and understand Korean
- Participant is willing and able to give informed consent for participation in the study
You may not qualify if:
- Patient who was diagnosed with lung cancer in the past.
- Individuals who are judged inappropriate for the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Seong-Gyu Kolead
Study Sites (1)
Korea University Guro Hospital
Seoul, South Korea
Related Publications (1)
Cho W, Kim JH, Jeong M, Kim MS, Lee J, Son H, Cheon C, Park S, Ko SG. Pattern identification of lung cancer patients based on body constitution questionnaires (BCQ) and glycoproteomics for precision medicine. Medicine (Baltimore). 2019 Jun;98(24):e16035. doi: 10.1097/MD.0000000000016035.
PMID: 31192960DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Prof.
Study Record Dates
First Submitted
December 20, 2017
First Posted
December 27, 2017
Study Start
September 16, 2015
Primary Completion
March 31, 2018
Study Completion
May 31, 2018
Last Updated
January 9, 2018
Record last verified: 2018-01
Data Sharing
- IPD Sharing
- Will not share